Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cipla
Chinese Patent Office
McKesson
Farmers Insurance
Fuji
Fish and Richardson
US Army
Citi

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017831

« Back to Dashboard

NDA 017831 describes DIDRONEL, which is a drug marketed by Mgi Pharma Inc and Apil and is included in two NDAs. Additional details are available on the DIDRONEL profile page.

The generic ingredient in DIDRONEL is etidronate disodium. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the etidronate disodium profile page.
Summary for 017831
Tradename:DIDRONEL
Applicant:Apil
Ingredient:etidronate disodium
Patents:0
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 017831

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Apil DIDRONEL etidronate disodium TABLET;ORAL 017831-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Federal Trade Commission
Moodys
US Department of Justice
AstraZeneca
Fish and Richardson
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.